MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-10-2026
Medpace Holdings Cash Conversion Cycle 2011-2026 | MEDP
Annual Cash Conversion Cycle Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.4 | 51.5 | 53.4 | 55 | 55.5 | 62.4 | 52.7 | 56.6 | 46.2 | 53.1 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.4 | 46.2 | 53.7 |
Quarterly Cash Conversion Cycle Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.9 | 51.1 | 48.6 | - | 52.4 | 50.1 | 51.6 | - | 52.6 | 52.8 | 53.7 | - | 29.6 | 29.2 | 56.7 | - | 53.7 | 52.7 | 56.3 | - | 63.8 | 71.7 | 62.6 | 61.8 | 65.7 | 66.3 | 65.7 | 63.4 | 67.9 | 71.6 | 60.6 | 67.3 | 68.5 | 71.4 | 69.7 | - | 67.5 | 68.7 | 66.4 | - | 32.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 71.7 | 29.2 | 58.1 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
111 | $ 110.3 | -2.8 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Soleno Therapeutics
SLNO
|
-398 | $ 30.28 | -4.87 % | $ 1.54 B | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
Neuronetics
STIM
|
17.3 | $ 1.4 | 4.89 % | $ 92.3 M | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
33.5 | $ 13.25 | -2.18 % | $ 3.76 B | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.61 | -0.7 % | $ 61.9 M |  Irlanda |
 |
BioNano Genomics
BNGO
|
166 | $ 1.15 | - | $ 6.26 M | USA |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 44.54 | -4.74 % | $ 2.66 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 23.99 | -2.87 % | $ 666 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 159.38 | -3.48 % | $ 7.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 196.09 | -1.04 % | $ 21.8 B | USA |
 |
Organovo Holdings
ONVO
|
-82.8 K | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
115 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Waters Corporation
WAT
|
731 | $ 289.91 | -3.54 % | $ 17.3 B | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
142 | $ 117.59 | -5.48 % | $ 18.7 B | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
44.9 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
150 | $ 8.85 | -3.33 % | $ 1.92 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Personalis
PSNL
|
-11.5 | $ 6.33 | -13.59 % | $ 375 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 264.96 | -1.27 % | $ 22 B | USA |
 |
Senseonics Holdings
SENS
|
36.1 | $ 6.45 | -1.68 % | $ 269 M | USA |
 |
Psychemedics Corporation
PMD
|
45.3 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-3.19 | $ 25.68 | -3.24 % | $ 33.3 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 16.68 | -4.52 % | $ 889 M | USA |
 |
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
-10.1 | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M |  Britain |
 |
VolitionRx Limited
VNRX
|
52.3 | $ 0.2 | 1.97 % | $ 19.2 M |  Singapore |
|
Biodesix
BDSX
|
41.7 | $ 14.27 | -2.26 % | $ 1.85 B | USA |